MENT (Trestolone) – synthetic androgen frame
Experimental synthetic steroid, a much stronger androgen than testosterone in laboratory measurements; developed as a male contraceptive.
The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

DETAILED OVERVIEW
What is MENT (Trestolone) – synthetic androgen frame?
Trestolone (MENT) is an experimental synthetic androgen, a modified form of testosterone that, in laboratory measurements, binds about 8–10 times more strongly to the cell's hormone sensors. The Population Council developed it as a male contraceptive, but development stalled for financial reasons; only a few small studies have been done in humans so far. It has never been approved as a medicine and is a controlled substance in Hungary and Poland; on the illegal market it is also sold mixed with testosterone.
It does not turn into DHT (dihydrotestosterone, a strong male hormone), so it acts more weakly than testosterone on the scalp and the prostate. It shuts down the body's own testosterone and sperm production; recovery is slow and not always complete. It can raise the hormone prolactin, which may bring a lower sex drive, erection problems and enlargement of the male breast. It worsens cholesterol values, causes largely irreversible masculinization in women, and must not be used in pregnancy. WADA bans it year-round.
Mechanism
AR agonist (8-10x Test) + progesterone receptor, 7α-methyl-19-nor-T, aromatizes weakly
Anabolic:Androgenic
~2300:650 (extrapolated in vitro AR-binding)
Half-life
~8 h (Ac), 5-7 d (Enan)
Onset
12-24 h (Ac IM), 48-72 h (Enan IM)
Legal status
Never an Rx, UGL only. Schedule III analog (USA), WADA-banned.
No anecdote collected yet.
Data console
Lab data
Sundaram K, Kumar N, Bardin CW. . 7 alpha-methyl-19-nortestosterone (MENT): the optimal androgen for male contraception. Ann Med. 1993;25(2):199-205..
Anderson RA, Wallace AM, Sattar N, Kumar N, Sundaram K. . 7α-methyl-19-nortestosterone maintains sexual behavior and mood in hypogonadal men. J Clin Endocrinol Metab. 1999;84(10):3556-62..
Suvisaari J, Sundaram K, Noé G et al. . Pharmacokinetics and pharmacodynamics of 7alpha-methyl-19-nortestosterone after intramuscular administration in healthy men. Hum Reprod. 1997;12(5):967-73..
Pope HG Jr, Wood RI, Rogol A, Nyberg F, Bowers L, Bhasin S. . Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev. 2014;35(3):341-75..
Hartgens F, Kuipers H. . Effects of androgenic-anabolic steroids in athletes. Sports Med. 2004;34(8):513-554..
Safety
Side effects, stop signs, contraindications
Side effects · 8
- Strong HPTA suppression: endogenous testosterone and sperm production shut down and fertility drops (MENT was originally a male contraceptive candidate precisely for this), with slow and not always complete recovery.
- Prolactin elevation from the 19-nor progestogenic activity: lowered libido, erectile dysfunction (a deca-dick-like effect), nipple discharge and progestogen-driven gynecomastia even when estrogen is low.
- Adverse lipid profile and cardiovascular strain: HDL (good cholesterol) drops moderately to markedly and LDL can rise, raising atherosclerotic and cardiac risk with prolonged use.
- Estrogenic effects from aromatization: MENT aromatizes to 7α-methylestradiol (weaker than plain estradiol but not zero) causing water retention, raised blood pressure and estrogen-driven gynecomastia, especially in the Test-containing mixture variants.
- Mood and psychiatric effects: irritability, aggression, sleep disturbance, and rarely depressive episodes linked to the progestogenic/prolactin activity, with increased risk in those with pre-existing psychiatric predisposition.
- Androgenic skin and hair effects: acne, oily skin, increased body hair and scalp hair loss in predisposed users; MENT does not convert to DHT, so scalp and prostate androgen effects are milder than testosterone but not absent.
- Injection-site reaction (PIP, pain, swelling, inflammation) more pronounced with the short Acetate mixture (lower solubility, frequent, even daily injections) and milder with the slow Enanthate mixture.
- Raised red blood cell count and hematocrit (as with androgens generally) thickening the blood and potentially increasing thrombosis and blood-pressure risk, especially with prolonged higher-dose use.
Contraindications · 7
- Women, especially in or considering pregnancy: MENT is an extremely strong androgen causing rapid and largely irreversible virilization (voice deepening, hair growth, clitoral enlargement) and posing a risk of fetal harm.
- Prolactinoma, hyperprolactinemia or any prolactin-sensitive condition: an absolute contraindication because of the 19-nor progestogenic activity, which worsens existing prolactin problems.
- Pre-existing cardiovascular disease, uncontrolled hypertension or an adverse lipid profile: the androgen's HDL-lowering, fluid-retaining and hematocrit-raising effects increase cardiovascular event risk.
- Current or near-future plans for fatherhood: strong HPTA suppression and shutdown of spermatogenesis markedly reduce fertility, with uncertain recovery.
- Psychiatric predisposition (depression, anxiety, aggression-control disorders): the progestogenic/prolactin and androgenic effects can trigger mood instability and depressive episodes.
- Hormone-sensitive cancer (prostate, breast) or undiagnosed prostate enlargement: androgenic stimulation can promote progression of hormone-dependent tumors and BPH.
- Adolescence / incomplete bone growth, and first-time AAS users: the extreme potency and the unknown, non-standardized MENT/Test ratio of the designer mixture make it especially risky.
Related Performance Compounds
Same therapeutic category
Studies
Related research and clinical findings
7 alpha-methyl-19-nortestosterone (MENT): the optimal androgen for male contraception
Sundaram K, Kumar N, Bardin CW.
7α-methyl-19-nortestosterone maintains sexual behavior and mood in hypogonadal men
Anderson RA, Wallace AM, Sattar N, Kumar N, Sundaram K.
Pharmacokinetics and pharmacodynamics of 7alpha-methyl-19-nortestosterone after intramuscular administration in healthy men
Suvisaari J, Sundaram K, Noé G et al.
Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement
Pope HG Jr, Wood RI, Rogol A, Nyberg F, Bowers L, Bhasin S.
Effects of androgenic-anabolic steroids in athletes
Hartgens F, Kuipers H.
Telegram
Have a question about MENT (Trestolone) – synthetic androgen frame?
Reach out to an advisor on Telegram. Performance compounds are presented with a harm-reduction approach, based on peer-reviewed evidence.
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
The information here is for educational and scientific purposes only. Performance-enhancing compounds (AAS, prohormones, stimulants, doping agents) are illegal without prescription in Hungary and most of the EU, and carry serious health and legal risks. WADA bans them in competitive sport. This is NOT a usage guide, and we do not encourage any illegal use. If you do use them, medical supervision and regular bloodwork are ESSENTIAL. Severe endocrine, cardiovascular, hepatic and psychiatric side effects are possible.
